Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 2 |
Pissara et al. | yes | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004077 | biotin-[acetyl-CoA-carboxylase] ligase activity | 4 | 10 |
GO:0016874 | ligase activity | 2 | 12 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 3 | 10 |
GO:0018271 | biotin-protein ligase activity | 3 | 10 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 91 | 93 | PF00675 | 0.357 |
CLV_PCSK_KEX2_1 | 223 | 225 | PF00082 | 0.461 |
CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.357 |
CLV_PCSK_PC1ET2_1 | 223 | 225 | PF00082 | 0.509 |
CLV_PCSK_SKI1_1 | 217 | 221 | PF00082 | 0.492 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.356 |
DEG_APCC_DBOX_1 | 91 | 99 | PF00400 | 0.556 |
DOC_MAPK_DCC_7 | 75 | 84 | PF00069 | 0.512 |
DOC_MAPK_gen_1 | 91 | 97 | PF00069 | 0.556 |
DOC_MAPK_MEF2A_6 | 75 | 84 | PF00069 | 0.512 |
DOC_MAPK_RevD_3 | 79 | 92 | PF00069 | 0.556 |
DOC_PP4_FxxP_1 | 63 | 66 | PF00568 | 0.438 |
DOC_USP7_MATH_1 | 105 | 109 | PF00917 | 0.562 |
DOC_USP7_UBL2_3 | 213 | 217 | PF12436 | 0.518 |
DOC_WW_Pin1_4 | 178 | 183 | PF00397 | 0.439 |
DOC_WW_Pin1_4 | 196 | 201 | PF00397 | 0.534 |
DOC_WW_Pin1_4 | 51 | 56 | PF00397 | 0.469 |
LIG_14-3-3_CanoR_1 | 50 | 55 | PF00244 | 0.489 |
LIG_BRCT_BRCA1_1 | 190 | 194 | PF00533 | 0.233 |
LIG_CtBP_PxDLS_1 | 231 | 235 | PF00389 | 0.505 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.512 |
LIG_FHA_1 | 60 | 66 | PF00498 | 0.477 |
LIG_FHA_2 | 133 | 139 | PF00498 | 0.498 |
LIG_FHA_2 | 196 | 202 | PF00498 | 0.326 |
LIG_FHA_2 | 251 | 257 | PF00498 | 0.450 |
LIG_LIR_Apic_2 | 49 | 55 | PF02991 | 0.500 |
LIG_LIR_Apic_2 | 62 | 66 | PF02991 | 0.595 |
LIG_LIR_Gen_1 | 188 | 196 | PF02991 | 0.315 |
LIG_LIR_Gen_1 | 209 | 219 | PF02991 | 0.514 |
LIG_LIR_Nem_3 | 140 | 146 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 188 | 193 | PF02991 | 0.249 |
LIG_LIR_Nem_3 | 209 | 214 | PF02991 | 0.520 |
LIG_LIR_Nem_3 | 241 | 245 | PF02991 | 0.384 |
LIG_MLH1_MIPbox_1 | 190 | 194 | PF16413 | 0.233 |
LIG_PDZ_Class_2 | 258 | 263 | PF00595 | 0.443 |
LIG_Pex14_1 | 190 | 194 | PF04695 | 0.342 |
LIG_SH2_STAT5 | 143 | 146 | PF00017 | 0.527 |
LIG_SH3_3 | 77 | 83 | PF00018 | 0.445 |
LIG_WRC_WIRS_1 | 208 | 213 | PF05994 | 0.464 |
LIG_WRC_WIRS_1 | 60 | 65 | PF05994 | 0.438 |
MOD_CDK_SPK_2 | 51 | 56 | PF00069 | 0.472 |
MOD_CK1_1 | 188 | 194 | PF00069 | 0.366 |
MOD_CK1_1 | 238 | 244 | PF00069 | 0.528 |
MOD_CK2_1 | 132 | 138 | PF00069 | 0.461 |
MOD_CK2_1 | 195 | 201 | PF00069 | 0.567 |
MOD_CK2_1 | 203 | 209 | PF00069 | 0.449 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.226 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.261 |
MOD_GlcNHglycan | 255 | 260 | PF01048 | 0.431 |
MOD_GSK3_1 | 196 | 203 | PF00069 | 0.525 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.566 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.522 |
MOD_NEK2_1 | 185 | 190 | PF00069 | 0.270 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.407 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.461 |
MOD_PKA_2 | 162 | 168 | PF00069 | 0.298 |
MOD_PKA_2 | 203 | 209 | PF00069 | 0.456 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.463 |
MOD_Plk_1 | 163 | 169 | PF00069 | 0.540 |
MOD_Plk_1 | 215 | 221 | PF00069 | 0.412 |
MOD_Plk_1 | 232 | 238 | PF00069 | 0.463 |
MOD_Plk_4 | 132 | 138 | PF00069 | 0.478 |
MOD_Plk_4 | 163 | 169 | PF00069 | 0.557 |
MOD_Plk_4 | 185 | 191 | PF00069 | 0.310 |
MOD_Plk_4 | 203 | 209 | PF00069 | 0.472 |
MOD_ProDKin_1 | 178 | 184 | PF00069 | 0.440 |
MOD_ProDKin_1 | 196 | 202 | PF00069 | 0.530 |
MOD_ProDKin_1 | 51 | 57 | PF00069 | 0.469 |
MOD_SUMO_for_1 | 74 | 77 | PF00179 | 0.562 |
MOD_SUMO_rev_2 | 26 | 34 | PF00179 | 0.383 |
TRG_ENDOCYTIC_2 | 143 | 146 | PF00928 | 0.527 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.477 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HUD5 | Leptomonas seymouri | 72% | 100% |
A0A0S4JE29 | Bodo saltans | 35% | 85% |
A0A1X0P3B0 | Trypanosomatidae | 51% | 100% |
A0A3R7NY08 | Trypanosoma rangeli | 47% | 100% |
A0A3S7X4E1 | Leishmania donovani | 91% | 100% |
A4HJ88 | Leishmania braziliensis | 84% | 100% |
A4I6N1 | Leishmania infantum | 91% | 100% |
D0A8L0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
Q4Q6F6 | Leishmania major | 91% | 100% |
Q59014 | Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) | 31% | 100% |
V5DNJ4 | Trypanosoma cruzi | 51% | 100% |